Holen Sie sich die Stockscreener-App
65.80
2.96%
1.89
Schlusskurs vom Vortag:
$63.91
Offen:
$64.16
24-Stunden-Volumen:
525.64K
Relative Volume:
0.88
Marktkapitalisierung:
$3.59B
Einnahmen:
$1.35B
Nettoeinkommen (Verlust:
$-217.48M
KGV:
-16.41
EPS:
-4.0106
Netto-Cashflow:
$191.43M
1W Leistung:
-1.14%
1M Leistung:
+7.29%
6M Leistung:
+24.01%
1J Leistung:
+38.18%
1-Tages-Spanne:
$63.58
$66.61
1-Wochen-Bereich:
$62.91
$67.42
52-Wochen-Spanne:
$32.48
$67.92
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
65.80 | 3.49B | 1.35B | -217.48M | 191.43M | -4.0106 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LSV Asset Management Raises Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC subject to activist investor interest2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru
What margin trends mean for LivaNova PLC stockWeekly Trade Summary & AI Based Buy/Sell Signal Reports - mfd.ru
Aug Ideas: Does LivaNova PLC stock benefit from AI growthJuly 2025 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Can LivaNova PLC outperform in the next rallyJuly 2025 Short Interest & Smart Money Movement Tracker - mfd.ru
Allianz Asset Management GmbH Makes New $7.69 Million Investment in LivaNova PLC $LIVN - MarketBeat
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
New York State Common Retirement Fund Acquires 93,267 Shares of LivaNova PLC $LIVN - MarketBeat
Bioelectric Medicine Market is expected to reach US$ 235.55 - openPR.com
LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges - DirectorsTalk Interviews
Responsive Playbooks and the LIVN Inflection - Stock Traders Daily
A Look At LivaNova (LIVN) Valuation After KeyBanc Upgrade And Renewed Medtech Optimism - Sahm
LivaNova Stock Checks Its Pulse: Can LIVN’s Recent Slide Set Up A Recovery Rally? - AD HOC NEWS
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What LivaNova (LIVN)'s KeyBanc Upgrade and Medtech Reassessment Means For Shareholders - simplywall.st
LivaNova stock reaches 52-week high at $65.95 By Investing.com - Investing.com Australia
LivaNova (LIVN) Upgraded to Overweight by KeyBanc - Finviz
What are KeyBanc’s Top MedTech Picks By Investing.com - Investing.com Nigeria
What are KeyBanc’s Top MedTech Picks - Investing.com
LivaNova (NASDAQ:LIVN) Sets New 1-Year HighHere's What Happened - MarketBeat
LivaNova stock reaches 52-week high at $65.95 - Investing.com
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up - Yahoo Finance
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026 - GlobeNewswire Inc.
Understanding the Setup: (LIVN) and Scalable Risk - Stock Traders Daily
Autotransfusion System Market is expected to reach US$ 1,094.30 - openPR.com
Emerald Mutual Fund Advisers Trust Purchases 26,202 Shares of LivaNova PLC $LIVN - MarketBeat
Cardiac Pacemaker Market Covering Prime Factors - openPR.com
SG Americas Securities LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN) Valuation As Shares Track Recent Momentum And Ongoing Losses - simplywall.st
These 4 Measures Indicate That LivaNova (NASDAQ:LIVN) Is Using Debt Safely - 富途资讯
Extracorporeal Membrane Oxygenation (ECMO) Machines Market - openPR.com
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - marketscreener.com
Should I buy LivaNova PLC (LIA) stock before earnings seasonEarnings Volatility Patterns & Small Investment Portfolio - bollywoodhelpline.com
Medical Implants Market Is Booming So Rapidly Growth by 2033 |Biotronik, Inc., Livanova Plc, NuVasive - openPR.com
Are Options Traders Betting on a Big Move in LivaNova Stock? - MSN
What risks investors should watch in LivaNova PLC stockEconomic Indicators Overview & Top Analyst Picks Available for Free - bollywoodhelpline.com
Wall Street Recap: Can LivaNova PLC maintain sales growth2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
LivaNova (NASDAQ:LIVN) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Chart Watch: Whats the fair value of LivaNova PLC stock2025 Growth vs Value & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Deep Brain Stimulation Devices Market Valuation Set to Achieve - openPR.com
LivaNova Announces Chief Legal Officer Resignation and Succession - The Globe and Mail
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins By Investing.com - Investing.com South Africa
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins - Investing.com UK
Does LivaNova PLC have strong fundamentalsEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - bollywoodhelpline.com
Market Trends: Does LivaNova PLC have pricing powerInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Macro Review: Is LivaNova PLC stock attractive for income investorsPortfolio Performance Summary & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
The Technical Signals Behind (LIVN) That Institutions Follow - Stock Traders Daily
LivaNova (LIVN) Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies PortfolioWhat's Changed - Sahm
Is LivaNova PLC stock a dividend growth opportunityPortfolio Gains Report & Growth Oriented Trade Recommendations - Улправда
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Livanova Plc-Aktie (LIVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):